Back to search

Article

Population Pharmacokinetics Study of Morinidazole in Patients with Moderate Hepatic Impairment

2018-05-02

Abstract excerpt

<h4>Objective</h4> Morinidazole is a novel third generation 5-nitroimidazole antimicrobial drug which has demonstrated substantial antibacterial activity against clinical isolates of anaerobe. The aim of this study was to build population pharmacokinetic (PPK) model of morinidazole among patients with hepatic impairment and to provide dosage adjustment strategy for morinidazole in patients with hepatic impairment...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3b9d502b-da2e-56f6-b224-2f9ca409636f
DOI
10.1101/312728
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Population Pharmacokinetics Study of Morinidazole in Patients with Moderate Hepatic ImpairmentDOI 10.1101/312728
Select a neighboring publication to make it the new centre.